Determination of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and its metabolites in human plasma and urine by column-switching high-performance liquid chromatography with ultraviolet detection

J Chromatogr B Biomed Sci Appl. 1997 May 9;692(2):397-404. doi: 10.1016/s0378-4347(96)00508-7.

Abstract

A simple, rapid and sensitive two column-switching high-performance liquid chromatographic (HPLC) method with ultraviolet detection at 210 nm has been developed for the determination of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (AY4166, I) and its seven metabolites in human plasma and urine. Measurements of I and its metabolites were carried out by two column-switching HPLC, because metabolites were classified into two groups according to their retention times. After purification of plasma samples using solid-phase extraction and direct dilution of urinary samples, I and each metabolite were injected into HPLC. The calibration graphs for plasma and urinary samples were linear in the ranges 0.1 to 10 microg ml(-1) and 0.5 to 50 microg ml(-1), respectively. Recoveries of I and its seven metabolites were over 88% by the standard addition method and the relative standard deviations of I and its metabolites were 1-6%.

MeSH terms

  • Chromatography, High Pressure Liquid / methods*
  • Cyclohexanes / blood
  • Cyclohexanes / pharmacokinetics*
  • Cyclohexanes / urine
  • Humans
  • Hypoglycemic Agents / blood
  • Hypoglycemic Agents / pharmacokinetics*
  • Hypoglycemic Agents / urine
  • Nateglinide
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / blood
  • Phenylalanine / pharmacokinetics
  • Phenylalanine / urine
  • Reference Standards
  • Spectrophotometry, Ultraviolet

Substances

  • Cyclohexanes
  • Hypoglycemic Agents
  • Nateglinide
  • Phenylalanine